This rule-based informatics solution pulls from the electronic health record to automate the election of an appropriate biosimilar therapy based on the patient's insurance and hospital formulary preferences, streamlining prior authorization and approval processes. This e-tool decreased administrative burden to providers, pharmacists, and prior authorization specialists and increased biosimilar utilization by 21.9%.
Modeled after the successful “one-day diagnosis” model developed at the Gustave Roussy Institute in France, St. Luke’s University Health Network’s 2024 ACCC Innovator Award winning One-Stop Breast Clinic streamlined the diagnostic process, reduced time to treatment, improved patient satisfaction, and decreased operational costs for patients with breast cancer.
